Ovarian cancer is the most lethal gynecologic malignancy and treatment strategies have remained unchanged for decades. A hallmark of tumour progression is the ability to rapidly develop new blood supply; however, aggressive growth signals result in dysfunctional blood vessels that reduce tumour perfusion and promote hypoxia. This tumour microenvironment promotes chemoresistance and suppresses natural and […]
Read More